Adicet Bio is a privately held, pre-clinical stage biotechnology company engaged in the design and development of cutting-edge immunotherapies for cancer and other disease indications, with a focus on novel universal immune cell therapies (uICT).
Company (Alive / Active)
200 Constitution Drive
Menlo Park, 94025
California, United States
|Investor||Investor Type||Location||Participating Rounds|